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Abstract
Background: The different physiological repertoire of CA3 and CA1 neurons in the hippocampus,
as well as their differing behaviour after noxious stimuli are ultimately based upon differences in the
expressed genome. We have compared CA3 and CA1 gene expression in the uninjured brain, and
after cerebral ischemia using laser microdissection (LMD), RNA amplification, and array
hybridization.
Results:  Profiling in CA1 vs. CA3 under normoxic conditions detected more than 1000
differentially expressed genes that belong to different, physiologically relevant gene ontology
groups in both cell types. The comparison of each region under normoxic and ischemic conditions
revealed more than 5000 ischemia-regulated genes for each individual cell type. Surprisingly, there
was a high co-regulation in both regions. In the ischemic state, only about 100 genes were found
to be differentially expressed in CA3 and CA1. The majority of these genes were also different in
the native state. A minority of interesting genes (e.g. inhibinbetaA) displayed divergent expression
preference under native and ischemic conditions with partially opposing directions of regulation in
both cell types.
Conclusion: The differences found in two morphologically very similar cell types situated next to
each other in the CNS are large providing a rational basis for physiological differences.
Unexpectedly, the genomic response to ischemia is highly similar in these two neuron types, leading
to a substantial attenuation of functional genomic differences in these two cell types. Also, the
majority of changes that exist in the ischemic state are not generated de novo by the ischemic
stimulus, but are preexistant from the genomic repertoire in the native situation. This unexpected
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influence of a strong noxious stimulus on cell-specific gene expression differences can be explained
by the activation of a cell-type independent conserved gene-expression program. Our data
generate both novel insights into the relation of the quiescent and stimulus-induced transcriptome
in different cells, and provide a large dataset to the research community, both for mapping
purposes, as well as for physiological and pathophysiological research.
Background
The brain harbours a large variety of neuron types and
sub-types, besides a large number of glial cells. These neu-
rons can differ strongly in their physiological tasks and
capacities, and can be very specialized. In addition, differ-
ent neuron types also display a quite specialized response
to pathophysiological influences. This is exemplified in
neurodegenerative disorders, where often mutations in
broadly expressed genes only cause pathology in one type
of neurons (e.g. SOD1 mutations only affect motoneu-
rons in ALS, Parkin mutations only affect dopaminergic
neurons of the substantia nigra in PD). Ultimately, the
cause of both differing physiology, as well as different vul-
nerability to pathophysiologic stimuli must lie in the
expressed genome in different cell type.
There are a number of approaches aimed to establish a
molecular brain atlas. This is mostly done by high-
throughput in-situ hybridizations, and automated image
acquisition systems (e.g. [1-4]). Alternatively or comple-
mentarily, systematic generation of mice expressing
marker proteins under control of large genomic elements
may be used [5]. However, these strategies approach the
problem on a gene-by-gene basis, and will not allow to
explore functional genomic differences between two cell
types on a statistical level.
At present, differences in global gene expression between
different neuron types in the quiescent brain are not well
studied. Moreover, there are hardly any systematic data
available that examine how common stimuli change the
functional genome in different neuron types. The main
reasons for this have been technical difficulties. However,
with the advent of laser microdissection, RNA amplifica-
tion, and high-density DNA-array systems such
approaches are now feasible [6,7].
Two very interesting neuron types for an exemplary study
of these questions are situated in the hippocampal sub-
fields CA (cornu ammonis)3 and CA1. First, the hippoc-
ampus is an intensively studied part of the brain, and a lot
of data on the physiological behaviour of these cell types
is available. Second, these cells are homogenously placed
in cell bands that are easily identifiable, and there is a rel-
atively low degree of contamination by other cells
(interneurons, glial cells). Third, these cells display a
strong difference in vulnerability to different disease stim-
uli, the most prominent being cerebral ischemia [8-11].
We have therefore performed a genome-wide comparison
of CA3 and CA1 gene expression in the uninjured brain,
and after cerebral ischemia using laser microdissection
(LMD), RNA amplification, and array hybridization.
Results
Experimental setup
We used competitive hybridizations on Agilent G4121
DNA arrays displaying app. 21318 gene products as 60
mer-oligonucleotides. The ischemic model we used was a
modified hypoxia/ischemia model as introduced by Van-
nucci and colleagues [12,13] (Fig. 1A). We dissected CA3
and CA1 hippocampal subfields by laser microdissection
from Thionin-stained cryosections (exemplary outline
shown on a NeuN stained section in Fig. 1B), and ampli-
fied the RNA. There was no difference in size distribution
of amplified RNA from different animals, different sub-
fields, or the experimental group (sham vs. ischemia) (see
Additional file 1). Gene regulation in CA1 vs. CA3 regions
from uninjured and ischemic animals (n = 4 each) was
determined in a total of 32 combinatorial hybridizations,
including dye-swap controls (Fig. 1C). Microarray data-
sets generated in this study have been submitted in
MIAME-compliant format to the EBI database [14].
Comparison of differential gene expression in the 
normoxic state
We searched for genes with stronger expression in CA3 or
CA1 by direct competitive hybridization of 4 samples
each. A total of 1035 genes were found with 566 being
stronger expressed in CA3, and 487 in CA1 (Fig. 2A; full
list in Additional file 2) (pfdr < 0.05).
The five most prominent genes overexpressed in CA3 or
CA1 are given in Fig. 2B: The gene with the strongest dif-
ferential expression in CA3 was claudin 22, a protein of
the claudin family which is involved in tight junction for-
mation [15]. There are indeed indications that puncta
adhaerentia at the mossy fiber – CA3 dendrite synaptic
sites contain ZO-1, a protein that connects claudin to the
actin cytoskeleton [16]. It is thus likely, that claudin 22
plays a CA3-specific role at these synapses.BMC Genomics 2007, 8:370 http://www.biomedcentral.com/1471-2164/8/370
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Experimental model and strategy Figure 1
Experimental model and strategy. Male C57/bl6 mice were subjected to a combined ischemia/hypoxia model which con-
sistently yields full hemispheric infarcts. A, TTC-stained coronal section 24 h after induction of ischemia/hypoxia demonstrate 
a full hemispheric infarct which fully covers the hippocampal region. B, The cutting outlines used for Laser microdissection 
from coronal cryosections are demonstrated on a section stained with an antibody against NeuN and a secondary Cy3-coupled 
antibody. Actual Laser microdissections in the experiments were performed on Thionin-stained sections. C, Scheme showing 
the strategy used for detection of differentially regulated genes from amplified RNA. Samples from CA3 and CA1 regions were 
hybridized on two-color oligonucleotide arrays (Agilent). Direct competitive hybridizations were performed for all combina-
tions: CA3 sham vs, CA1 sham, CA3 ischemia vs CA1 ischemia, CA3 ischemia vs CA3 sham, and CA1 ischemia vs CA1 sham. 
All experiments were also dye-swapped, and means of the two corresponding values used for further analyses. Arrays were 
statistically analyzed using linear modelling (limma, R).
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Bok (Bcl-2 related ovarian killer) is a pro-apoptotic mem-
ber of the Bcl family. In dividing cells, Bok is regulated by
the cell cycle [17-19]. Its function has however been pri-
marily studied in reproductive tissue, and nothing is
known about its role in neurons.
Pvrl3 (or PRR3 or Nectin3) is the poliovirus-virus related
receptor 3. This group of genes is involved in cell-cell
interactions [20,21], and Nectin3 has been shown to be
critical for the formation of puncta adherens junctions
(PAJs) between CA3 dendrites and mossy fibres
[16,22,23]. It is interesting to find two genes belonging to
the same protein complex among the 5 most enriched
genes in CA3 vs. CA1.
Rerg is a RAS-related tumor suppressor gene first identi-
fied in breast cancer [24,25]. Its role in the brain and the
CA3 region is completely unknown at present. Finally,
DEHAL1 (Iodotyrosine dehalogenase 1) is a gene
involved in deiodination of mono and diiodotyrosines
[16,22,26]. The potential function of this protein in CA3
is completely enigmatic at present.
The gene most exclusively expressed in CA1 is mpped1
(metallophosphoesterase domain containing 1;
NM_172610). There is no information available on this
protein in the databases. Also, the second gene found here
is an unknown EST (NM_183136). A gene enriched by a
factor of 44-fold was preproenkephalin
(NM_001002927). The CA1-selective expression of this
gene is again confirmed on the in-situ level by the system-
atic gene-brain-mapping database BGEM. Latrophilin 2 is
one of the receptors for alpha-latrotoxin [27]. While lat-
rophilin 1 seems to be expressed in all hippocampal sub-
fields there is not much information available on the role
of latrophilin 2. Copines finally are a class of proteins
with Ca2+ and phospholipid-binding properties that are
thought to be involved in membrane trafficking [28].
However, very little specific information on their role in
the brain is available.
GO analysis of CA3 vs. CA1 in the native state
We next performed a gene ontology analysis in the catego-
ries biological process and molecular function to system-
atically assess relevant funtional gene groups. Gene
ontology analysis with the L2l-tool [29] demonstrated a
number of functional groups that were significantly over-
represented in the CA3-enriched genes (Fig. 3). Several
main topics appear evident when looking at biological
process categories: First, there are several large gene
groups relating to differentiation: "neuron differentia-
tion", "nervous system development", "regulation of dif-
ferentiation". Second, there is a small group of genes
classified as "regulation of synaptic transmission" and
similar categories. Third, there are two groups related to
CA1 and CA3 neurons display a different gene expression  repertoire in the native state Figure 2
CA1 and CA3 neurons display a different gene 
expression repertoire in the native state. Result of the 
comparison of CA3 and CA1 regions in the native animal. A, 
We detect 1035 genes that are differentially expressed in the 
CA3 and CA1 region in sham-treated animals, 566 are signifi-
cantly enriched in CA3, 487 in CA1 (pfdr < 0.05; differentially 
regulated genes in red). B, Bar graph showing enrichment fac-
tors for the 5 most differentially expressed genes in CA3 and 
CA1. The enrichment factors reflect relative abundance of 
gene expression in CA3 over CA1 or vice versa, and were 
calculated by dividing the mean of the gene abundance in 
CA3 by CA1 or vice versa. Bok, Bcl-2 related ovarian killer; 
pvrl3, poliovirus receptor-related 3; rerg, RAS-like, estrogen-
regulated; dehal1, Iodotyrosine dehalogenase 1; mpped1, 
metallophosphoesterase domain containing 1; penk1, pre-
proenkephalin 1.
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cellular catabolism: "alcohol catabolism" and "monosac-
charide catabolism". Interestingly, there are also two cate-
gories relating to "amyloid precursor protein
metabolism". For the genes relatively upregulated in CA1,
we find only three categories in the biological process cat-
egory enriched, most notably the "gamma-aminobutyric
acid signaling pathway", with the GABA-A receptor subu-
nits alpha 1 and 3, and beta 2, "cAMP biogenesis", and
"transmembrane receptor tyrosine phosphatase signaling
pathway".
This differential enrichment of gene categories suggests a
much higher degree of plasticity mechanisms of CA3 neu-
rons in the hippocampus compared to CA1 that are
reflected by large groups of genes in categories related to
"differentiation" or "neurite morphogenesis", and by
"regulation of synaptic transmission". The second theme
cluster refers to energy generation (e.g. "monosaccharide
catabolism") harbouring genes like hexokinase 2, phos-
phofructokinase, or fructose-bisphosphate aldolase. This
suggests a higher enrichment of genes involved in energy
generation, and may provide one explanation for a higher
resistance against hypoxic/ischemic events in CA3 neu-
rons.
For the GO category "Molecular function" we also find a
remarkable difference between CA3 and CA1 (Fig. 3,
lower part): CA3-enriched categories include "ephrin
receptor activity", "endopeptidase inhibitor activity",
"carbohydrate kinase activity", and "transferase activity,
transferring hexosyl groups". Particularly interesting are
the "endopeptidase inhibitor activity" that harbours
among others 5 different serpin-type endopeptidase
inhibitors (SerpinB9, SerpinF1, SerpinA7, SerpinG1, and
Spink1). A number of reports finds neuroprotective func-
tions of different serpins in models of cerebral ischemia
[30,31]. "Carbohydrate kinase activity" again identifies
genes involved in energy metabolism such as 6-phosphof-
ructo-2-kinase/fructose-2,6-biphosphatase 3, hexokinase
2, or phosphofructokinase. The group "transferase activ-
ity, transferring hexosyl groups" contains a total of 10
genes involved in carbohadrate transfer and proteoglykan
modifikation (e.g. N-acetylgalactosaminyltransferase 14
(GalNAc-T14), fucosyltransferase 8, mannosyl (alpha-
1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltrans-
ferase), and suggests a high acitivity in CA3 neurons in
modulating the cell surface and the extracellular space.
Finally, the category "ephrin receptor activity" (contains
EPHA3, EPHA4, EPHA5, EPHA7, EPHB1) underlines the
notion of a high degree of plasticity potential in CA3, e.g.
in axon guidance.
CA1-enriched categories include: "hydrolase activity,
hydrolyzing O-glycosyl compounds", "adenylate cyclase
activity","glucosidase activity","sulfotransferase activity",
"ligand-gated ion channel activity", and "mannosidase
activity". Enrichment of "Adenylate cyclase activity" is
derived from CA1-overexpression of adenylate cyclases 1,
6 and 8. "Ligand-gated ion channel activity" contains the
already mentioned GABA-A receptor subunits, the alpha 5
subunit of the nicotinic cholinergic receptor, or the TRP
channels, subtype C, members 3 and 4. Interestingly,
while CA3 has an enrichment in carbohydrate moiety
addition, CA1 is enriched in genes that remove carbohy-
drate chains, such as glucosidases and mannosidases. In
addition, CA1 is significantly enriched in a number of sul-
fotransferases.
We then asked the question whether the differential gene
expression pattern observed here has any potential com-
monalities to gene lists in the literature. Using the L2L
tool we discovered significant overlaps with 10 out of 811
lists. First, there is a significant overlap with genes down-
regulated in the hippocampus with aging (two lists
detected) [32]. Among these genes were synapsin II and
the Eph receptor A4, likely relating to declining plasticity
mechanisms in CA3. Second, there was a remarkable over-
lap with hypoxia-induced genes [33]: BCL2/adenovirus
E1B 19 kDa interacting protein 3 (BNIP3), hexokinase 2,
phosphoribosyl pyrophosphate synthetase 1, platelet
phosphofructokinase, enolase 1 (alpha), endothelin 2,
fructose-bisphosphate aldolase A, and the prostaglandin-
endoperoxide synthase 2 (prostaglandin G/H synthase
and cyclooxygenase). This overlap encourages the notion
from above that genes are enriched in CA3 whose relative
overexpression in the native state of the pyramidal cells
offers protection against subsequent hypoxia. The relative
overexpression of genes involved in glcolysis
(hexokinase2, phosphofructokinase, and fructose-
bisphosphate aldolase) supports the enrichment of genes
related to ATP generation found in the gene ontology
analysis above. It seems that CA3 neurons have a higher
reserve of energy generation in contrast to CA1 which pro-
vides an attractive hypothesis for their relative resistance
to hypoxia.
Confirmation of differential gene expression
To exemplarily confirm the regional-specific gene expres-
sion found we performed immunostaining for the Bcl-
family member Bok (Fig. 4). In the hippocampus we find
strong, but cellularly heterogenous expression in the CA3
field. There are single positive cells to be found in the CA2
region, and none in CA1. Bok is expressed again in the
subiculum, and in the dentate gyrus. Apart from the hip-
pocampal formation, Bok is expressed in the cerebral cor-
tex. Thus, we could confirm the differential expression
pattern of one exemplary gene on the protein level.
A second, more systematic approach to verifying our
results would be a comparison to databases harbouringBMC Genomics 2007, 8:370 http://www.biomedcentral.com/1471-2164/8/370
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Gene ontology analysis for CA3- and CA1-enriched genes in the native state Figure 3
Gene ontology analysis for CA3- and CA1-enriched genes in the native state. Bar graph depicting gene ontology 
(GO) analysis of the genes significantly overexpressed in CA3 or CA1. The upper part of the graph shows the GO category 
"Biological process", the lower part "Molecular function". GO analysis were performed using the web-based L2L tool [29]. For 
"Biological process" there is a strong emphasis on terms related to neuron differentiation, synaptic function, and energy metab-
olism in CA3, and to GABA-signaling in CA1. For "Molecular function" we find enrichment of groups like ephrin receptors, 
serin-type protease inhibitors, and carbohydrate moiety transfer activities. In contrast in CA1 we observe an enrichment in 
deglycosylating activity, ligand-gated ion channels, and sulfotransferase activity. Black, expected matches; red, observed 
matches.
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The Bok-protein is localized to CA3 Figure 4
The Bok-protein is localized to CA3. Micrographs showing immunohistochemical detection of Bok (Bcl-2 related ovarian 
killer) protein expression in the hippocampus of C57/bl6 mice. A, Overview of the hippocampal formation (original magnifica-
tion (OM) 10×). Bok preferentially localizes to th CA3 subfield, with some staining in the dentate gyrus. Apart from the hippoc-
ampus stining is visible in the cortex. B,C,D,E Staining in the CA3 subfield (B), in the CA3-CA2 transition (C), in the CA1 field 
(D), and in the CA1-subiculum transition (E) (OM 20×). In CA2 only few single neurons are detectable that stain positive for 
Bok, in CA1 staining is absent and is evident again in the subiculum. F, Close-up of CA3 neurons (OM 60×). Although quite spe-
cifically localized to CA3 Bok displays a patchy staining of neurons within this subfield.
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hippocampal expression patterns. One project that uses a
systematic approach towards localization of gene expres-
sion in the brain is BGEM (Brain Gene Expression Map
[4]). This repository provides a selection of in-situ hybrid-
ization of over 2400 genes, which have been selected by
neuroscientists or by their expression in the brain [4]. For
our purposes, the selection of genes can however be
regarded as random. We have manually compared
selected overrepresented genes in CA3 or CA1 to this data-
base.
In the list of the 5 most overrepresented genes in CA3 we
find Bok, pvrl3 and for CA1 penk. All genes showed the
selective hippocampal subfield expression predicted by
our data. Additional file 3 shows a selection of genes that
are found among the 1035 differentially expressed genes
and the BGEM database, and confirm the expected sub-
field distribution between CA3 and CA1. The in-situ
hybridizations also nicely correlate with the induction fac-
tor found with respect to the relative staining intensities of
both areas.
Similar confirmation of our data could be obtained by
querying another web-based in-situ-hybridization reposi-
tory of the brain, the Allen brain atlas [34]. We confirmed
cell-type specific enrichment for a number of regulated
genes that were not contained in the BGEM set, for exam-
ple the GABA-A receptor subunit alpha1 and others (Addi-
tional file 3). These comparisons are admittedly
hampered by the difficulty in querying these databases,
and extracting informations about the coverage of our
gene lists by these collections, as well as by the need to vis-
ually inspect all images. Thus we cannot estimate the
likely false positive or negative rate for our lists from these
comparisons at the moment. However, it is noteworthy
that we did not detect any false positives by this manual
approach.
Another approach to systematically check the validity of
our data is comparison to similar studies. Indeed, a
number of data have been published on differences of
gene expression in the native state in the hippocampus,
the most thorough by Lein and colleagues [35]. There is a
high degree of overlap in genes identified as being over-
represented in either CA3 or CA1. We identified the neph-
roblastoma-overexpressed gene (Nov) in our gene lists as
an CA1-enriched gene (CA1/CA1 sham ratio 2.29) which
was verified by Lein et al. using in-situ hybridization. In
CA3, one of the highest hits in our list was the Bcl2-related
ovarian killer (Bok; relative regulation 33.4-fold com-
pared to CA1) that was also found and verified by Lein et
al Other genes that were commonly identified by both
approaches were the transforming growth factor beta 2
(Tgfb2), protein kinase C, delta (Prkcd), myosin Vb
(Myo5b), copine 9 (NM_170673.3) (versus copine 6 in
the Lein screen). In summary, we could demonstrate a
high reliability of our approach based on RNA-amplifica-
tion.
Genes regulated in CA3 and CA1 by hypoxia/ischemia
Comparing ischemic samples from CA3 or CA1 to their
respective normoxic controls yielded a large number of
regulated genes. In CA3, a total of 5243 genes were found
to be regulated by ischemia (pfdr < 0.05; see Additional file
4). Of those, 2559 were upregulated by ischemia, and
2619 downregulated (Fig. 5A). GO analysis revealed only
two terms in biological process that were overrepre-
sented,"microspike biogenesis" and "response to inor-
ganic substance". Comparison to regulated gene lists
found overlaps with a variety of stress-induced paradigms
(e.g. heatshock, UV-irradiation), and genes induced by
TNFa-treatment, NF-kB or p53. The list of overlapping
genes with p53 induction harbours genes such as cyclin-
dependent kinase inhibitor 1A (p21, Cip1), Fas ligand,
immediate early response 3, or the growth arrest and
DNA-damage-inducible, alpha (GADD45A). In CA1 we
find 5511 genes altered, 2649 of those upregulated by
ischemia (Fig. 5B; see Additional file 5).
Comparing both lists of significantly regulated genes, we
find a surprising overlap of 4070 genes at pfdr < 0.05,
1173 only regulated in CA3, and 1441 only regulated in
CA1. However, the significance cutoff at pfdr < 0.05 is
arbitrary, and the exclusiveness of genes in the non-over-
lapping set is relative. Indeed, the impression of a co-reg-
ulation of genes in CA1 and CA3 by hypoxia/ischemia is
overwhelming, with a high correlation (Fig. 5C; R2 of
0.84). The slope of the correlation equation is essentially
1, implying that there is no systematic difference in the
gene regulation of CA1 and CA3 neurons confronted with
the ischemic stimulus. Using direct comparison of
ischemic CA3 or CA1 samples, only 97 genes were found
to be differentially expressed in CA3 or CA1 under
ischemic conditions (red, pfdr < 0.05; Fig. 5C; full list in
Additional file 6). Of those, 38 were stronger regulated in
CA3 24 h after ischemia, and 59 in CA1. Fig. 5D shows the
5 most strongly enriched genes in CA3 and CA1, respec-
tively.
Interestingly, the majority of genes different in the
ischemic state were genes that had already been detected
as different in the normoxic state (total of 65 genes), while
51 genes overlapped with genes induced by ischemia in
CA3 and/or CA1.
In order to further validate the lists of genes identified we
compared regulation factors for genes for the sham or
ischemia group obtained from the array analyses to quan-
titative PCR (see Additional file 7). We find a good corre-
lation between both assessment methods (PearsonBMC Genomics 2007, 8:370 http://www.biomedcentral.com/1471-2164/8/370
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Gene expression in CA3 versus CA1 after ischemia Figure 5
Gene expression in CA3 versus CA1 after ischemia. A,B Scatterplots showing the results of direct competitive hybridi-
zations of both subfields from ischemic animals and the non-ischemic controls (means of n = 4 experiments for each region). In 
each of the hippocampal subregions more than 5000 genes could be identified exhibiting differential expression upon ischemia. 
A. 5243 differentially expressed genes were detected in the CA3 region. B. 5511 differentially expressed genes were detected 
in the CA1 region. Red: significantly regulated genes (pfdr < 0.05; differentially regulated genes in blue). C, A total of 97 genes is 
significantly different between ischemic CA3 and ischemic CA1 regions (scatterplot; blue are significantly regulated genes pfdr < 
0.05). D, Bar graph showing the 5 most different genes with preference for CA3 or CA1 with their relative enrichment factors 
(prdma, pr-domain containing protein 8; Inhba, Inhibin beta A; Bok, Bcl-2 related ovarian killer; Sytl4, synaptotagmin-like 4; rbp 
4, retinol binding protein 4; mpped1, metallophosphoesterase domain containing 1; mrg1, myeloid ecotropic viral integration 
site-related gene 1, alternative names: meis2, stra10).
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correlation coefficient 0.75). We also performed immu-
nohistochemistry on one gene regulated in both sham
and ischemia (Sytl4), and confirmed the distribution pref-
erence to CA3 (see Additional file 8).
Gene ontology overrepresentation analysis revealed that
functional gene groups that were relatively upregulated in
CA3 include categories such as "synaptic transmission",
"cell-cell signaling", "neurotransmitter secretion", but
also "axon guidance" and "nervous system development"
under biological process. Under molecular function, there
are two enriched categories, "peroxidase function" and
"calcium binding". One of the two genes contained in
"peroxidase function" is interestingly a peroxidasin
homologue (A_51_P300456, AK122223), a protein that
has so far not been studied in a mammalian setting [36].
This gene category may be relevant for counteracting oxy-
gen radical formation, one pathomechanism in cerebral
ischemia. In the CA1 overrepresented genes we only
found one category enriched, "retinol binding" under
molecular function. This category contained only 2 genes,
retinol-binding protein 1 and 4.
Thus, there is a major difference in the groups of genes
that are relatively overrepresented in the two hippocam-
pal regions after ischemia, however, the number of differ-
entially expressed genes in CA1 and CA3 under ischemic
conditions is unexpectedly low.
Ischemia attenuates gene expression differences between 
CA3 and CA1
We asked what the reasons for this apparent overall disap-
pearance of individualitistic gene expression profiles of
these two cell types under ischemic conditions were, while
the ischemic stimulus itself produced massive gene
expression changes in both cell types. One technical rea-
son could have been a strong increase in statistical vari-
ance in the ischemic samples caused by adding the
experimental variance to the basic biological fluctuation
between individual mice, and thus strongly decreasing
power for the detection of differences. However, the dis-
tribution of standard deviations in both groups was
highly similar, and cannot account for a 10-fold decrease
in power (97 vs. 1035 genes detected at the same signifi-
cance level) [37] (see Additional file 9). Indeed, the
spread of CA3/CA1-ratios was broader in the normoxic
than in the ischemic situation (Fig. 6A), suggesting that
the major cause of reduction in the number of cell-type-
specifically enriched genes was truely caused by a relative
convergence of gene expression in these two cell types. We
contrasted CA3/CA1 ratios in the normoxic and ischemic
state (Fig. 6B). The regression line deviates strongly from
the diagonal (slope 0.44; R2 = 0.34), reflecting the broader
spread of CA3/CA1 ratios in the normoxic situation. The
vertical compressive deformation of the scatter plot also
appears symmetrical, implying that the loss of relative
gene expression enrichment is equally affecting CA3 and
CA1. While this compression effect under ischemic condi-
tions affects the broad majority of genes, only 15 discrete
genes demonstrate a significantly divergent behaviour
under normoxic and hypoxic conditions with regard to
their CA3 or CA1 preference (see Additional file 10). In
nearly all cases, this relative shift is caused by attenuation
of the extent of differential preference under ischemia.
Several genes display a particularly impressive shift:
Proenkephalin is 44-fold more abundant in CA1 in the
native state, but looses this strong preference in ischemia
(only 3-fold more abundant in CA1). Proenkephalin has
been characterized as an immediate-early gene in the hip-
pocampus in various seizure models [38-40], we did how-
ever not find data concerning effects of proenkephalin on
neuronal survival or possible functions in cerebral
ischemia. The gene with the most prominent change in
the other direction is claudin-22. This gene looses CA3-
specificity with ischemia (69-fold overexpression in CA3
in the normoxic vs. 2.6-fold overexpression in the
ischemic state). Claudin-22 is also the gene with the high-
est overall specificity to the CA3 region, and has been
implicated in puncta adhaerentia junction formation
between CA3 pyramidal cells and mossy fibers (see
above). There are no links to ischemia at present. The
most interesting, however singular, case is Inhibin beta A
(Inhba) (A_51_P239750; NM_008380), where ischemia
led to a full reversal of the expression preference from
CA1- to CA3-neurons (from a relative overexpression of
2.86-fold in the CA1-area under normoxic conditions to
an overexpression of 9.1-fold in the CA3-region under
ischemic conditions (total relative change 26-fold)). This
change was caused by a concomitant upregulation in CA3
(5.02-fold), and a downregulation in CA1 (0.55-fold) by
ischemia. This is also the highest overall change in the rel-
ative distribution of gene expression noted in CA3 and
CA1. We verified this behaviour by quantitative PCR for
Inhibin beta A (Fig. 6C), and find good correlation.
Inhibin/Activin beta A induction has indeed been previ-
ously observed in global gene expression analysis [41-43].
Induction of activin appears to be involved in the neuro-
protective effects of bFGF [44], and thus the reversal of
expression from CA1 to CA3 after an ischemic stimulus is
one attractive candidate for mediating the ischemia toler-
ance of CA3 neurons.
In summary, contrary to our expectations, and despite
massive induction of gene expression changes by ischemia
in two distinct cell types, individual gene expression dif-
ferences between CA3 and CA1 are strongly diminished
under ischemic conditions by non-directional changes in
CA3 and CA1.BMC Genomics 2007, 8:370 http://www.biomedcentral.com/1471-2164/8/370
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Discussion
Characteristics of our approach
We have aimed at comparing the functional genome in
two subsections of the hippocampus harbouring diverse
neuron types in the native state and after a strong tran-
scriptional stimulus using laser microdissection and RNA
amplification with a highly linear protocol [6,7,45]. We
have chosen CA3 and CA1 fields as these fields are well-
studied concerning their differing physiology, are situated
in close proximity in the brain, and are readily separable
from each other (e.g. without using immunohistochemi-
cal markers). Although we have not excised single neu-
rons from the two areas, we have carefully excised the
pyramidal cell layers that harbour neurons at high density
with relatively few non-neuronal cell types (e.g. astrocytes
or endothelial cells). About 10% of the neurons in the
pyramidal layer are estimated to be interneurons. We
therefore assume that the vast majority of genes identified
as differeing between the two regions are of neuronal ori-
gin. This assumption is backed for example by the clearly
neuronal origin of the majority of functional gene ontol-
ogy groups identified. Also, although a small percentage
of non-neuronal cell types are present, these are unlikely
to differ in their gene expression between CA1 and CA3 as
is expected from the neurons, and therefore are unlikely to
contribute to the differences observed here. Comparable
studies using even less sophisticated approaches (e.g.
manual dissection such as Lein et al. [35]) have yielded a
set of purely neuronal genes.
As strong transcriptional stimulus we have chosen
hypoxia/ischemia, as these two hippocampal fields are
known to display differing vulnerabilities to this insult,
and ischemia is one of the strongest stimuli known in the
brain, thus likely providing statistically robust differences.
We used two-color hybridization, and directly cross-com-
pared samples from CA3 and CA1 in the native and
ischemic state in all combinations.
The main questions we sought to approach with this study
was how the functional genome of two neuron types dif-
fers in the native state, changes after an ischemic stimulus,
and if and how these changes are related.
Validation of datasets
Regulated datasets have been extracted from the array
experiment using stringent statistical criteria (false discov-
ery rate correction by the Benjamini-Hochberg method).
We sought to show the validity of the extracted genes by
three approaches: First, we compared genes regulated in
the non-ischemic situation by comparison to online in-
situ-hybridization databases, where we have validated the
differential expression of over 10% of the genes detected
in this dataset by visual inspection. Second, we have veri-
fied the differential expression of a total of 9 genes from
Ischemia blunts the gene expression differences in CA3 and  CA1 Figure 6
Ischemia blunts the gene expression differences in 
CA3 and CA1. A, Box-Whisker plot showing the narrow-
ing of CA3/CA1 ratios in ischemic vs. naive animals. B, Plot-
ting CA3/CA1 ratios in ischemia vs. sham reveals deviation 
from the diagonal. Difference ratios are attenuated by 
ischemia regardless of preferential CA3 or CA1 expression 
(red: pfdr < 0.05). C, Inhibin beta A displays the highest 
change in preference between the native and ischemic state. 
The gene expression preference actually reverses from 
higher expression in CA1 in the native brain to higher 
expression in CA3 in the ischemic state. Verification with 
quantitative PCR shows comparable values to the array-
derived ratios.
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the non-ischemic and ischemic datasets by quantitative
PCR, with generally good accordance of observed direc-
tion and extent of regulation. Third, we have performed
immunohistochemistry for two genes. Overall we believe
that these approaches provide an excellent trust basis for
our lists. It has to be noted however that all verification
approaches are based on exemplary and random sam-
pling of genes, and do not provide proof in a systematic
and statistically valid way that all genes in the lists are dif-
ferentially regulated. Indeed, we expect 5% false positives
in our lists according to the Benjamini-Hochberg method.
Also, we have not approached the more difficult question
of false negatives. This does however not impact on the
validity of the general conclusions drawn from the study,
since false negatives and positives are expected to be gov-
erned by random factors.
Ischemic model
We chose the Vannucci model of a combined global
hypoxia and hemispheric ischemia, as this is more robust
than other models (e.g. filament model MCAO), and reli-
ably affects the whole hippocampus. We have carefully
optimized hypoxia times (see methods section) to pro-
duce a highly reproducible hemispheric ischemia with
hippocampal involvement and tolerable mortality. This
indeed resulted in an acceptable variance between
ischemic samples. In contrast to global ischemic model
(e.g. 2-vessel occlusion with hypotonia [46]) this model
also produces a full infarct that is readily detectable by
TTC-staining.
Comparison to similar approaches
We have conducted a detailed gene expression analysis of
CA1 and CA3 gene expression in the native state, and the
first systematic analysis of gene expression under
ischemia. Moreover, our study is the first attempt to dis-
sect the status quo of gene expression in two similar hip-
pocampal structures harbouring different neurons under
native conditions and after a strong transcriptional stimu-
lus such as hypoxia/ischemia, and relate these to changes
in the individual regions.
Regarding gene expression differences in the native state,
a number of labs have undertaken systematic approaches
to dissect gene expression in hippocampal subfields in
man and rodents [35,47-51]. Ginsberg and Che have
studied CA3 and CA1 differences in human post-mortem
tissue [50]. Similar to our approach, they have microdis-
sected neurons from CA3 or CA1 using LMD. They report
a total of 20 genes changed, among these GABRA1 and
GABRA2 as overexpressed genes in CA1, corroborating
our data for the human situation. The authors have how-
ever used a very limited DNA array (~120 genes con-
tained). A similar study was undertaken by Torres-Munoz
and colleagues, also by using microdissection of single
neurons from CA3 or CA1 from post-mortem brains [49].
The authors report a total of 60 genes significantly over-
represented in CA3 or CA1. The study by Bonaventure and
colleagues compares microdissected nuclei and CA1 and
CA3 in Wistar rats [47]. It is however unclear from the
paper how many genes were found to be statistically dif-
ferent between CA1 and CA3. Of the five genes given in
the paper as most enriched in CA3 or CA1, we find RGS14
in our list of 1035 significantly changed genes also as an
CA1-enriched gene product. A comprehensive analysis
was performed by Lein et al. [35,52]. Lein et al. have man-
ually dissected hippocampal subregions from the mouse
(CA1, CA2, CA3, DG), and categorized gene expression
according to the preferential expression. A total of 104
genes were selected according to their relative rank in pat-
tern formation and their preferential distribution to dif-
ferent regions of the hippocampus verified by in-situ-
hybridization. As the main purpose of this study was to
find prominent marker genes for the hippocampal subre-
gions, the authors have not used rigorous parametric sta-
tistics to determine the totality of genes that is changed,
but rather used manual inspections of patterns for selec-
tion of the 104 most different genes. In contrast, we define
the population of genes that are significantly changed in
the functional genome by stringent statistical criteria (pfdr
< 0.05). Also, we use LMD for dissection which is more
accurate than manual dissection. There is a high degree of
overlap in the genes reported by the authors and in our
study, cross-validating both approaches. A very similar
approach to ours was taken by Datson et al. [51]. The
authors compared gene expression in the dentate gyrus to
the CA3 region using laser microdissection and Affymetrix
chip hybridization with rigorous statistical testing. They
report a similar number of differentially expressed genes
(724) to our study (1035).
Regarding the question of differences under ischemia, a
number of labs have looked at single gene product distri-
butions to the hippocampal subfields CA3 and CA1 after
ischemia [53-62], however, no one has undertaken a sys-
tematic attempt to define differences in CA1 and CA3 in
the ischemic state.
Ischemia dampens genomic differences between neuronal 
cell types
In the native state, there is a substantial degree of differ-
ence in gene expression (>1000 genes differentially
expressed between CA3 and CA1) which likely forms the
basis for the differing physiological and connective prop-
erties of these cells. Our lists of differentially expressed
genes now provides a large dataset for generating and test-
ing new hypotheses on the origin of differing properties of
these cell types.BMC Genomics 2007, 8:370 http://www.biomedcentral.com/1471-2164/8/370
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We have used a strong transcriptional stimulus to study
the behaviour of the functional genome of two similar
neuronal cell types to a common perturbation. The
ischemic paradigm is particularly well-suited because it is
one of the strongest stimuli known for changing gene
expression in the brain, and because these two cell types
display differential vulnerability to ischemic insults, with
the CA3 neurons being more resistant. The number of
genes detected as significantly differing in their abun-
dance in CA3 vs CA1 was unexpectedly lower in the
ischemic state (97 genes) than under normoxic condi-
tions (1035 genes). The majority of the genes detected was
also preferentially enriched in CA3 or CA1 under native
conditions. This dampening of cell-type specific gene
expression profiles appears counterintuitive in view of the
massive induction of gene expression changes in each
individual neuron type by the ischemic stimulus (both >
5000 genes changed, i.e. app. 25% of the functional
genome present on the DNA array). However, this mas-
sive induction is indeed the explanation for this behav-
iour: Obviously ischemia evokes a conserved, largely
(neuronal) cell-type-independent program in gene
expression changes, which attenuates pre-existing differ-
ences.
An alternative explanation for the disappearance of cell-
type specificity in gene expression in the hippocampus
would be centered on a general shut-down of transcrip-
tion in damaged neurons that would thus eliminate dif-
ferences. However, we and others have done numerous
studies in different ischemic paradigms, and it is believed
that ischemia is one of the strongest transcriptional stim-
uli known in the brain and in neurons. This is indeed
underlined by the strong ischemia-induced regulation of
gene expression in this study (close to 25% of the scanned
genome was altered, both up- and downregulated). One
could however argue that these changes are not derived
from neurons, but from non-neuronal cells that contami-
nate the pyramidal layers. This would consequently imply
that one would primarily detect regulated genes of non-
neuronal origin under ischemic conditions. However, the
major functional groups (GO-term) regulated are neuro-
nal, such as "synaptic transmission", "neurotransmitter
secretion", "axon guidance" or "nervous system develop-
ment". And among the most differing genes in CA3 and
CA1 under ischemic conditions are genes like synaptotag-
min-like 4, or latrophilin-2 which are exclusively neuro-
nal in origin. We therefore believe that the explanation for
the observed dampening of field-specific differences is
indeed due to the activation of a common transcriptional
program rather than to shutting down transcription.
To broaden this important conclusion it will be necessary
in the future to examine a much larger number of different
neuron types. These results also may have implications for
therapeutic strategies in ischemic diseases of the brain: It
would be advantageous to select target mechanisms for
pharmacological interference from the pathways and ele-
ments that are common to different (neuronal) cell types.
Returning to one initial question of the genomic basis for
the physiological and pathophysiological differences
between two types of neurons, there is a large repertoire of
functional genomic differences genes and pathways in the
native state that can form the basis for correlating physio-
logical properties of these two cell types. However, single
gene candidates for the differing susceptibility of CA3 and
CA1 neurons are limited (<100), and these are certainly
attractive entry points for detecting new targets in
ischemic diseases of the brain.
Conclusion
By using laser microdissection and RNA amplification we
could identify the differential functional genome under
normoxic and hypoxic conditions in the two hippocam-
pal subfields likely forming the basis of differing physio-
logical and pathophysiological behaviour of these cells.
Our approach was successful, and lends itself to replica-
tion with different paradigms. We have provided the most
thorough and rigid catalogue to date of gene expression
differences in the CA3 and CA1 subfield of the hippocam-
pus, both under native conditions, as well as after a strong
ischemic stimulus. These data will be both useful for brain
mapping projects, as well as for researchers studying the
physiology of the hippocampus (e.g. in learning and
memory paradigms). Moreover, our datasets are of con-
siderable value for research into ischemic pathophysiol-
ogy.
The most surprising outcome of this analyses is however
that the strong transcriptional stimulus hypoxia/ischemia
leads to a substantial reduction in pre-existing cell-type-
specific gene expression patterns, instead of generating
new or enhancing existing differences.
Methods
Ischemic model
Hypoxia-ischemia was induced in 3-month- old male
C57BL6 mice by a modification of the procedure devel-
oped by Vannucci and co-workers [12,13]. Animals were
anaesthetized with halothane (4% in 70% N2O: 30% O2).
A small incision was made in the neck and the right com-
mon carotid artery was exposed and ligated with 4–0 sur-
gical silk in three separate locations. The incision was
closed, and the animal allowed to recover with access to
food and water for 3 hours. Prior to exposure to hypoxia,
mice were placed in a 35.5°C water bath for 10 minutes
followed by hypoxic exposure which comprised 10 min
(6% O2/94%N2) and 25 min (8% O2/92%N2). At the end
of the hypoxic interval, animals were allowed to recover inBMC Genomics 2007, 8:370 http://www.biomedcentral.com/1471-2164/8/370
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room air for 30 min and then return to their cage with free
access to food and water for 24 houres. Animals were re-
anaesthetized with Halothane, transcardially perfused
with HBSS, decapitated, and brains were frozen on dry ice.
During establishing of the protocol a number of animals
were examined by TTC-staining to determine ischemic
damage. The morphology of the pyramidal cell layer after
the Vannucci model remains intact after 24 hrs. Animal
procedures adhered to German ethical standards and were
approved by the relevant regulatory authorities
(Regierungspräsidium Karlsruhe).
Laser Microdissection
Mouse brains were cut into 8 µm thick horizontal sections
using a cryotome (Leica). For identification of the pyram-
idal cell layers sections were stained with Thionin (0.5%
in a 0.066 M Na-acetate buffer). Air-dried sections were
immersed for 30 seconds, and rinsed once with water. For
laser microdissection we selected three consecutive hori-
zontal sections (Bregma as zero reference: -5.64; interau-
ral connection as zero reference: 4.36). Laser
microdissection (Leica LMD) was used to dissect the CA1
and CA3 pyramidal layers identified by comparison to
stereotaxic atlas data. Excised regions from 3 consecutive
sections were collected together, and further processed. N
= 4 brains per group were used.
RNA amplification
Each RNA sample was linearly amplified by two consecu-
tive rounds of T7 polymerase-driven amplification [63].
The precipitated total RNA of each LMD sample was
reverse transcribed with a first-strand synthesis mix com-
prising 10 U Superscript III (Invitrogen, Karlsruhe, Ger-
many), 1 U Superasin (Ambion, Huntingdon, UK) and
0.5 pmol of T7-T18V primer by incubating for 2 h at 50°C
after second-strand synthesis with 6 U DNA polymerase I,
2 h at 22°C with 0.2 U RNaseH, and 15 min at 16°C with
4 U T4 DNA polymerase I (Invitrogen). The T7 promoter-
tagged cDNA template was purified by standard phenol
extraction and ethanol precipitation. This cDNA was used
for first round amplified antisense RNA production apply-
ing a MegaScript kit (Ambion) and purified with an RNe-
asy Mini Kit (Qiagen) according to the manufacturer's
instructions. Second round amplification was performed
accordingly but using T7-tagged random primer for first-
strand cDNA synthesis and T18V primer for second-strand
synthesis, yielding amplified sense RNA. UV measure-
ments at 280 and 260 nm and 2100 Bioanalyzer runs
using the RNA-6000 Nano-LabChip (Agilent, Böblingen,
Germany) were used to ensure the quality and quantity of
the sense RNA produced. The yield varied from 40 to 80
µg. As RNA-marker we used the RNA-ladder 6000
(Ambion), with the following sizes: 0.2, 0.5, 1, 2, 4, and 6
kb.
Microarray analysis
The sense RNA samples were fluorescently labelled using
the CyScribe post-labelling kit (Amersham Biosciences,
Freiburg, Germany) according to the manufacturer's
instructions. Subsequently, the corresponding CA1 and
CA3 samples were hybridized pairwise to DNA arrays har-
bouring 21.318 gene probes as 60 mer-oligonucleotides
(#G4121A, Agilent). Accordingly, the corresponding
sham and ischemia samples were also hybridised pair-
wise. Hybridization was performed following the instruc-
tions of the array manufacturer but using 2 µg labelled
probe. All arrays were analysed with the Agilent DNA
array scanner and the ARRAYVISION V6.0 image software
(Imaging Research, St Catharines, Canada).
Statistical analysis
Data were log-transformed and normalized using the
Lowess algorithm. Statistical evaluation of the expression
changes was performed in the "R" statistical environment
(version 1.091) by using the BioConductor packages
"marray" [64] for data access and primary analysis and the
package "limma" which implements a moderate t-test
based on Bayesian statistic. This moderate t-test allows for
a comparably reliable estimation of the SD even if only
few replicates are available. The resulting p-value was cor-
rected for multiple testing using the false discovery rate
method (FDR) of Benjamini and Hochberg [65]. P-values
were adjusted to a false-discovery rate of 5 %.
Quantitative PCR
RNA of microdissected brain regions was amplified as
described [45]. cDNA was synthesized from 5 µg ampli-
fied RNA (2 rounds) using oligodT primers, superscript II
reverse transcriptase (Gibco) using standard conditions.
Quantitative PCR was performed using the Lightcycler sys-
tem (Roche Diagnostics, Mannheim, Germany) with
SYBR-green staining of DNA double-strands. Cycling con-
ditions were as follows: 5 min 95°C, 5 sec 95°C, 10 sec
60°C, 30 sec 72°C; 10 sec 84°C for 45 cycles for Inhibin
beta-2as and cyclophilin. The same annealing tempera-
ture was used for the amplification of Protocadherin 8
(Pcdh8), Neuritin 1 (Nrn1), and Spondin 1 (Spon1), but
measurement was carried out at 76°C melting tempera-
ture. An annealing temperature of 62°C and a melting
temperature of 79°C was used for Calbindin 28 K (Calb1)
and RAS-like, estrogen-regulated, growth inhibitor (Rerg).
As cycling conditions for measurement of Synaptotagmin-
like 4 (Sytl4) and retinol binding protein 4 (Rbp4) served
an annealing temperature of 66°C and a measuring tem-
perature of 82°C and 88°C, respectively. Melting curves
were determined using the following parameters: 95°C
cooling to 50°C; ramping to 99°C at 0.2°C/sec. The fol-
lowing primer pairs were used: "mInhibin beta-2s" GGA
GGG CTG GAA GAG GAA AAG GAA, "mmInhibin beta-
2as" TAA GGT TGG CAA AGG GGC TGT GAC (productBMC Genomics 2007, 8:370 http://www.biomedcentral.com/1471-2164/8/370
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328 bp), "mmProtocad 8_3734s" GCT AAG TGG AAG
TTA CTG CCA AAG, "mmProtocad 8_3974as" AGT GAC
AGA GCT TAC AGA GAA CCG (product 240 bp),
"mmNrn 1_1098s" TCC ACG TGG GAA TCA GCC GGT
G, "mmNrn 1_1352as" TGG ACC TGA ACG AGG GGC
ATC G (product 254 bp), "mmSpon 1_3770s" GAG GAT
GTT GAT CTC AGC TGT GAG, "mmSpon 1_4016as" TGA
ACA GGC TCT CGT GTG TTA AGG (product 246 bp),
"mm Calb1-1293s" CTT CTA TCT GGC GGA AGG GAT
GG, "mm Calb1-1533as" ACT CTC TGG CAG TAG ACT
TCT TGG (product 240 bp), "mm Rerg-1710s" CAG TAA
GTT GGC CAC ATG CCT TGT, "mm Rerg-1918as" CCA
AAT CTC AGT ATA TGG GGC AGG (product 208 bp),
"mm Sytl4-3242s" GTG GAT GGA ATT CCC CAG CCA
TTC, "mm Sytl4-3656as" GAA CAA GTC TGA GCC TGG
GCT CTC (product 414 bp), "mmRbp4-567s" GGA AGT
GTG TGC AGA CAT GGT GGG, "mmRbp4-903as" GGA
GGG CCT GCT TTG ACA GTA ACC (product 336 bp),
"mmNpy2r-2752s" GTT GCA CTT CTC TGG ATG CTG
ACG, "mmNpy2r-3122as" GCT CCT TCA GAA TGA CTG
TGC AGA (product 370 bp). Specificity of products was
ensured by melting point analysis and agarose gel electro-
phoresis. cDNA content of samples was normalized to the
expression level of Cyclophilin (primers: "cyc5" ACC CCA
CCG TGT TCT TCG AC, "acyc300" CAT TTG CCA TGG
ACA AGA TG). Relative regulation levels were derived
after normalization to cyclophilin.
Immunohistochemistry
For immunohistochemistry, sections of paraffin-embed-
ded tissues (2 µm) were deparaffinated and microwaved
(citrate buffer at 500 W for 10 min). Afterwards, sections
were incubated at room temperature with the respective
antisera (α-Bok: #4521, Cell Signaling, 1:100; α-Synapsin
II: #VAS-SV061, Stressgen, 1:100) over night at 4°C in a
humid chamber. Staining was visualized using the ABC
technique with DAB as chromogen (DAKO).
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Additional file 1
Size distribution of amplified RNA from CA1 and CA3 areas. A, 
Shown are electropherograms generated with the Agilent Bioanalyzer 
from 2nd round amplified RNA from CA1 or CA3 of 4 animals (2 sham, 
2 ischemia-treated). B, Marker lane with corresponding sizes (nt, nucle-
otides), and corresponding curve. C, Shown are the corresponding graphs. 
There is no difference in size distribution between CA1 and CA3, nor 
between sham- and ischemia-treated animals. The bulk of the amplified 
RNA ranges between 200 to 2000 nt.
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List of all significantly regulated genes in CA3 vs CA1 (native state). 
HTML file containing all significantly regulated genes in CA3 vs CA1 in 
the native state, with Agilent probe numbers, accession numbers, gene 
names, enrichment factors ("M (CA3/CA1")), and false-discovery-rate 
corrected p-values. M indicates direction and extent of enrichment: Num-
bers >1 indicate preferential expression in CA3, numbers <1 in CA1.
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Additional file 3
Genes with differential expression in CA3 and CA1 under native con-
ditions: Verification by detection in brain mapping projects. Shown are 
genes which had significantly differing distribution to CA3 and CA1. 
Selected genes with matches in brain mapping projects (BGEM or Allen 
Brain Atlas) are given with the gene symbol, gene name, Refseq accession 
number, Agilent probe number, preference of enrichment, and enrichment 
factor, and location in or link to microgrpahs of in situ hybridizations. All 
genes that were found are confirmed by the in-situ hybridizations. There 
is also general good correlation of the enrichment factors and visual 
impressions of the staining intensities in CA3 or CA1.
Click here for file
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Additional file 4
List of all significantly regulated genes in CA3 ischemic vs. sham. 
HTML file containing all genes significantly regulated in CA3 between 
the ischemic and the sham group. Given are Agilent probe numbers, acces-
sion numbers, gene names, enrichment factors ("M (ICA3/SCA3")), and 
false-discovery-rate corrected p-values.
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